Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev Colomb Psiquiatr (Engl Ed) ; 52(1): 73-77, 2023.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-37031021

RESUMO

INTRODUCTION: Before cataloguing a morbid process as a "mental disorder", it is essential to bear in mind the importance of early diagnosis of causes of non-psychiatric origin for a possible clinical presentation. For this reason, we will try to reflect this fact, which it seems necessary to remember even though it is well known, since it can be overlooked in emergency situations in the hospital setting, with the consequences derived from an incomplete diagnosis and with the potential life-threatening risk for the patient. CASE PRESENTATION: A 13-year-old female adolescent, who presented an acute clinical picture suggestive of dissociative disorder. She required hospital admission for diagnostic-therapeutic clarification, and neuroimaging findings led to an initial diagnosis of a neoplastic lesion in the brain stem and, finally, as ischaemic lesion of vasculitic origin in said location. DISCUSSION: A differential diagnosis was proposed through the different psychic and non-psychic aetiologies of the clinical picture, but the intervention of the hospital's paediatric service was necessary for orientation and definitive affiliation, given the suspicion of non-psychiatric illness after a torpid evolution in spite of psychotherapeutic and psychopharmacological interventions. CONCLUSIONS: Through the presentation and review of a clinical case that happened in our hospital, we must insist on an adequate comprehensive approach to the patient, especially with the child-adolescent population, when faced with an acute clinical presentation and without previous studies at a relevant physical level.


Assuntos
Transtornos Psicóticos , Feminino , Adolescente , Humanos , Hospitalização , Diagnóstico Diferencial
2.
Rev. colomb. psiquiatr ; 52(1)mar. 2023.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1536123

RESUMO

Introducción: Antes de catalogar un proceso morboso como trastorno mental, es imprescindible tener presente la importancia del diagnóstico precoz de causas de origen no psiquiátrico para una posible presentación clínica. Por ello, trataremos de reflejar este hecho, que se antoja necesario recordar aunque sea bien sabido, ya que puede pasarse por alto en situaciones de urgencia en el ámbito hospitalario, con las consecuencias derivadas de un cribado incompleto y con el potencial riesgo vital para el paciente. Presentación del caso: Adolescente mujer, de 13 años, que presentó un cuadro clínico agudosugestivo de carácter disociativo. Se precisó su ingreso hospitalario para la aclaración diagnóstico-terapéutica, y mediante neuroimagen se diagnosticó inicialmente como lesión neoplásica en el tronco del encéfalo y, finalmente, como lesión isquémica de origen vasculítico en dicha localización. Discusión: Se planteó un diagnóstico diferencial a través de las diferentes etiologías tanto psíquicas como no psíquicas del cuadro clínico, pero fue necesaria la intervención del servicio de pediatría hospitalario para la orientación y filiación definitiva, ante la sospecha de enfermedad no psiquiátrica tras una evolución tórpida a pesar de intervenciones psicoterapéuticas y psicofarmacológicas. Conclusiones: A través de la presentación y revisión de un caso clínico que sucedió en nuestro hospital de trabajo, se debe insistir en un adecuado abordaje integral del paciente, especialmente con población infanto-juvenil, ante una presentación clínica aguda y sin previas evaluaciones físicas de relevancia.


Introduction: Before cataloguing a morbid process as a "mental disorder", it is essential to bear in mind the importance of early diagnosis of causes of non-psychiatric origin for a possible clinical presentation. For this reason, we will try to reflect this fact, which it seems necessary to remember even though it is well known, since it can be overlooked in emergency situations in the hospital setting, with the consequences derived from an incomplete diagnosis and with the potential life-threatening risk for the patient. Case presentation: A 13-year-old female adolescent, who presented an acute clinical picture suggestive of dissociative disorder. She required hospital admission for diagnostic-therapeutic clarification, and neuroimaging findings led to an initial diagnosis of a neoplastic lesion in the brain stem and, finally, as ischaemic lesion of vasculitic origin in said location. Discussion: A differential diagnosis was proposed through the different psychic and nonpsychic aetiologies of the clinical picture, being the intervention of the hospital's paediatric service necessary for orientation and definitive affiliation, given the suspicion of non-psychiatric illness after a torpid evolution in spite of psychotherapeutic and psychopharmacological interventions. Conclusions: Through the presentation and review of a clinical case that happened in our hospital, we must insist on an adequate comprehensive approach to the patient, especially with the child-adolescent population, when faced with an acute clinical presentation and without previous studies at a relevant physical level.

3.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-34238583

RESUMO

INTRODUCTION: Before cataloguing a morbid process as a "mental disorder", it is essential to bear in mind the importance of early diagnosis of causes of non-psychiatric origin for a possible clinical presentation. For this reason, we will try to reflect this fact, which it seems necessary to remember even though it is well known, since it can be overlooked in emergency situations in the hospital setting, with the consequences derived from an incomplete diagnosis and with the potential life-threatening risk for the patient. CASE PRESENTATION: A 13-year-old female adolescent, who presented an acute clinical picture suggestive of dissociative disorder. She required hospital admission for diagnostic-therapeutic clarification, and neuroimaging findings led to an initial diagnosis of a neoplastic lesion in the brain stem and, finally, as ischaemic lesion of vasculitic origin in said location. DISCUSSION: A differential diagnosis was proposed through the different psychic and nonpsychic aetiologies of the clinical picture, being the intervention of the hospital's paediatric service necessary for orientation and definitive affiliation, given the suspicion of non-psychiatric illness after a torpid evolution in spite of psychotherapeutic and psychopharmacological interventions. CONCLUSIONS: Through the presentation and review of a clinical case that happened in our hospital, we must insist on an adequate comprehensive approach to the patient, especially with the child-adolescent population, when faced with an acute clinical presentation and without previous studies at a relevant physical level.

4.
Rev. psiquiatr. salud ment. (Barc., Ed. impr.) ; 13(4): 184-191, oct.-dic. 2020. tab
Artigo em Espanhol | IBECS | ID: ibc-198684

RESUMO

OBJETIVOS: Analizar los cambios en las tendencias de la mortalidad por suicidio según comunidad autónoma y sexo en España durante el período 1980-2016 utilizando modelos de regresión joinpoint. MÉTODOS: Los datos de mortalidad se obtuvieron del Instituto Nacional de Estadística. Para cada comunidad autónoma y sexo, se calcularon las tasas brutas y estandarizadas. El análisis de regresión joinpoint se utilizó para identificar los puntos más adecuados en los que se produjo un cambio estadísticamente significativo en la tendencia. RESULTADOS: El análisis joinpoint permite diferenciar comunidades en las que las tasas permanecen a lo largo de todo el periodo de estudio estables tanto en hombres (Cantabria, Castilla-La Mancha) como en mujeres (Canarias y Cantabria) y otras con un descenso continuado (Extremadura en hombres y mujeres y Castilla-La Mancha en mujeres). En aquellas comunidades en las que se observan cambios en la tendencia se aprecia, en casi todas ellas, un primer periodo de incremento en las tasas tanto en hombres como en mujeres. Las tendencias más recientes muestran divergencias entre las diferentes comunidades autónomas así, en los hombres, Andalucía, Canarias, Castilla-León, Comunidad Valenciana, Galicia, Murcia, País Vasco y La Rioja muestran tendencias descendentes significativas mientras que Cataluña y Madrid muestran incrementos significativos (2007-2016: 2,4% y 2010-2016: 18,7%, respectivamente). Algo similar se observa en las mujeres, para las que Andalucía, Castilla y León, Comunidad Valenciana, Galicia, Murcia, País Vasco y La Rioja muestran tendencias descendentes mientras que en Baleares, Cataluña y Madrid la tendencia es ascendente (2001-2016: 5,0%; 2006-2016: 4,2% y 2010-2016: 18,7% respectivamente). CONCLUSIONES: La mortalidad por suicidio varía ampliamente a nivel de comunidad autónoma, tanto en términos de nivel de mortalidad como de tendencias. Poco se sabe sobre los determinantes de las tendencias observadas y, por lo tanto, se necesitan más estudios


OBJECTIVES: To analyse the changes in mortality trends by suicide according to Autonomous Community and sex in Spain during the period 1980-2016 using joinpoint regression models. METHODS: Mortality data were obtained from the Instituo Nacional de Estadística. For each Spanish autonomous community and sex, crude and standardised rates were calculated. The joinpoint analysis was used to identify the best-fitting points where a statistically significant change in the trend occurred. RESULTS: The joinpoint analysis allows to differentiate areas in which the rates remain stable in men (Cantabria, Castilla-La Mancha) and women (Canary and Cantabria) throughout the study period and others with a continued decline (Extremadura in both men and women and Castilla-La Mancha in women). In those communities where changes in the trend are observed, in almost all of them, there is a first period of increase in rates in both men and women. The most recent trends show divergences between the different autonomous communities and, in men, Andalusia, the Canary Islands, Castilla-León, the Valencian Community, Galicia, Murcia, the Basque Country and La Rioja show significant downward trends, while Catalonia and Madrid show significant increases (2007-2016: 2.4% and 2010-2016: 18.7% respectively). Something similar is observed in women where Andalusia, Castilla y León, Valencian Community, Galicia, Murcia, País Vasco and La Rioja show downward trends while in the Balearic Islands, Catalonia and Madrid the trend is upward (2001-2016: 5.0%; 2006-2016: 4.2% and 2010-2016: 18.7% respectively). CONCLUSIONS: Suicide mortality varies widely among the Spanish autonomous communities, both in terms of mortality level and trends. Little is known about the determinants of observed trends and, therefore, more studies are needed


Assuntos
Humanos , Masculino , Feminino , Suicídio/tendências , Mortalidade/tendências , Análise Espacial , Modelos Logísticos , Espanha/epidemiologia , Geografia
5.
Rev Colomb Psiquiatr (Engl Ed) ; 49(3): 208-210, 2020.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32888666

RESUMO

INTRODUCTION: Attention deficit hyperactivity disorder has a prevalence of 1-4% of the Spanish school population. Its treatment consists of giving amphetamine derivatives and, recently, non-stimulant drugs, without finding any differences in efficacy in the studies performed. CLINICAL CASE: A 7-year-old girl was referred from neurology due to learning delay and behaviour disorders. Diagnosed as likely ADHD, treatment was started with immediate release methylphenidate, and later with an osmotic release oral system (OROS) methylphenidate. When alopecia areata appeared, this treatment was withdrawn. After the re-introduction of modified release methylphenidate 30:70, symptom control was achieved without the appearance of alopecia. DISCUSSION: There is a published history of two cases of alopecia areata with OROS methylphenidate that resolved after increasing the dose of the drug without clearly knowing the reason for this event. There is no consensus on the priority use of the immediate release formula or the OROS methylphenidate.


Assuntos
Alopecia em Áreas/induzido quimicamente , Estimulantes do Sistema Nervoso Central/efeitos adversos , Metilfenidato/efeitos adversos , Administração Oral , Transtorno do Deficit de Atenção com Hiperatividade/tratamento farmacológico , Estimulantes do Sistema Nervoso Central/administração & dosagem , Criança , Preparações de Ação Retardada , Feminino , Humanos , Metilfenidato/administração & dosagem
6.
Rev. colomb. psiquiatr ; 49(3): 208-210, jul.-set. 2020.
Artigo em Espanhol | LILACS, COLNAL | ID: biblio-1149829

RESUMO

RESUMEN Introducción: El TDAH tiene una prevalencia del 1-4% de la población escolar española. Su tratamiento se realiza con derivados anfetamínicos y, recientemente, con fármacos no esti mulantes; los estudios realizados no han encontrado diferencias de eficacia. Caso clínico: Niña de 7 arios llegó derivada desde neurología por retraso en el aprendizaje y trastornos de conducta. Orientada como TDAH, se inició tratamiento con metilfenidato de liberación inmediata y posteriormente con la fórmula OROS; apareció alopecia areata y se retiró el tratamiento. Tras la reintroducción de metilfenidato de liberación modificada 30:70, se consiguió controlar los síntomas sin que apareciera alopecia. Discusión: Hay antecedentes publicados de 2 casos de alopecia areata con metilfenidato OROS, que se resolvieron tras el aumento de dosis del fármaco, aunque no se conoce clara mente el motivo de este suceso. No hay consenso sobre el uso prioritario de la fórmula de liberación inmediata o la fórmula OROS del metilfenidato.


ABSTRACT Introduction: Attention deficit hyperactivity disorder has a prevalence of 1-4% of the Spanish school population. Its treatment consists of giving amphetamine derivatives and, recently, non-stimulant drugs, without finding any differences in efficacy in the studies performed. Clinical case: A 7-year-old girl was referred from neurology due to learning delay and behaviour disorders. Diagnosed as likely ADHD, treatment was started with immediate release methylphenidate, and later with an osmotic release oral system (OROS) methylphenidate. When alopecia areata appeared, this treatment was withdrawn. After the re-introduction of modified release methylphenidate 30:70, symptom control was achieved without the appearance of alopecia. Discussion: There is a published history of two cases of alopecia areata with OROS methylp henidate that resolved after increasing the dose of the drug without clearly knowing the reason for this event. There is no consensus on the priority use of the immediate release formula or the OROS methylphenidate.


Assuntos
Humanos , Feminino , Criança , Alopecia , Metilfenidato , Transtorno do Deficit de Atenção com Hiperatividade , Preparações Farmacêuticas , Alopecia em Áreas , Dosagem
7.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32674993

RESUMO

OBJECTIVE: To assess the effects of age, period and cohort suicide mortality trend in Spain (1984-2018). METHODS: Mortality and population data were obtained from the National Institute of Statistics. The analysis of the effect of age, period of death and birth cohort on the evolution of suicide mortality in the period 1984-2018 was performed using a web tool for age-period-cohort analysis provided by the Division of Cancer Epidemiology and Genetics of the National Cancer Institute of the USA. RESULTS: Rates increase with age (age effect) in both sexes. The period effect shows, in males, an increase over the period 1984-1998 followed by a significant decrease until 2018. In females, rates remain stable over the period 1987-2002, decrease during 2007-2012 (p < 0.05) and eventually stabilise. In both males and females, the risk decreases in each successive birth cohort between 1904 and 1939. Subsequently, the risks increase until the birth cohort of the period 1964-1974 after which the risk decreases for males and remains stable for females. CONCLUSION: A better understanding of the effects of the birth cohort could open new doors in suicide prevention.

8.
Rev. psiquiatr. salud ment. (Barc., Ed. impr.) ; 13(2): 57-62, abr.-jun. 2020. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-193403

RESUMO

OBJETIVOS: Analizar los cambios en las tendencias de la mortalidad por suicidio en España durante el periodo 1980-2016 utilizando modelos de regresión joinpoint. MÉTODOS: Los datos de mortalidad se obtuvieron del INE. Para cada sexo, las tasas específicas por grupo de edad y estandarizadas (general y truncada) (ASR) se calcularon por el método directo (utilizando la población estándar europea). El análisis joinpoint se utilizó para identificar los puntos más adecuados donde se produjo un cambio estadísticamente significativo en la tendencia. RESULTADOS: La tasa de mortalidad por suicidio ajustada por edad en hombres pasó en el periodo de estudio de 9,8/100.000 varones en 1980 a 11,8 en el año 2016, con un incremento anual medio del 0,8%. En las mujeres, las tasas se incrementaron un 1,0% anual pasando de 2,7/100.000 mujeres en 1980 a 3,7 en 2016. El análisis joinpoint identificó 3 puntos de inflexión en las tasas, tanto en hombres (1986, 2000 y 2010) como en mujeres (1986, 2004 y 2010), que identifican cambios en la tendencia. En el periodo 2010-2016 las tasas se incrementan en las mujeres, mientras que en los hombres las tasas permanecen estables. CONCLUSIONES: Nuestro trabajo muestra un marcado aumento en la mortalidad por suicidio en las mujeres españolas (2010-2016), mientras que en los hombres las tasas permanecen estables. Poco sabemos sobre los determinantes del aumento y, por ello, son necesarios más estudios


OBJECTIVES: To analyse changes in suicide mortality trends in Spain between 1980-2016 using joinpoint regression models. METHODS: Mortality data were obtained from the INE. For each gender, age-group-specific and standardised (overall and truncated) rates (ASR) were calculated by the direct method (using the European standard population). The joinpoint analysis was used to identify the best-fitting points where a statistically significant change in the trend occurred. RESULTS: Age adjusted mortality rates due to suicide in men was 9.8/100,000 males in 1980 and 11.8 in 2016, with an average annual increase of .8%. In women, the rates increased by 1.0% per year from 2.7 women per 100,000 in 1980 to 3.7 in 2016. The joinpoint analysis identified three turning points in the rates for both men (1986, 2000 and 2010) and women (1986, 2004 and 2010), which identify changes in the trend. In the period 2010-2016 the rates increase in women while in men the rates remain stable. CONCLUSIONS: Our work shows a marked increase in mortality by suicide in Spanish women (2010-2016) while in men the rates remain stable. Little is known about the determinants of the increase and, therefore, more studies are needed


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Suicídio/estatística & dados numéricos , Causas de Morte/tendências , Mortalidade/tendências , Espanha/epidemiologia
9.
Rev Psiquiatr Salud Ment (Engl Ed) ; 13(4): 184-191, 2020.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-31680020

RESUMO

OBJECTIVES: To analyse the changes in mortality trends by suicide according to Autonomous Community and sex in Spain during the period 1980-2016 using joinpoint regression models. METHODS: Mortality data were obtained from the Instituo Nacional de Estadística. For each Spanish autonomous community and sex, crude and standardised rates were calculated. The joinpoint analysis was used to identify the best-fitting points where a statistically significant change in the trend occurred. RESULTS: The joinpoint analysis allows to differentiate areas in which the rates remain stable in men (Cantabria, Castilla-La Mancha) and women (Canary and Cantabria) throughout the study period and others with a continued decline (Extremadura in both men and women and Castilla-La Mancha in women). In those communities where changes in the trend are observed, in almost all of them, there is a first period of increase in rates in both men and women. The most recent trends show divergences between the different autonomous communities and, in men, Andalusia, the Canary Islands, Castilla-León, the Valencian Community, Galicia, Murcia, the Basque Country and La Rioja show significant downward trends, while Catalonia and Madrid show significant increases (2007-2016: 2.4% and 2010-2016: 18.7% respectively). Something similar is observed in women where Andalusia, Castilla y León, Valencian Community, Galicia, Murcia, País Vasco and La Rioja show downward trends while in the Balearic Islands, Catalonia and Madrid the trend is upward (2001-2016: 5.0%; 2006-2016: 4.2% and 2010-2016: 18.7% respectively). CONCLUSIONS: Suicide mortality varies widely among the Spanish autonomous communities, both in terms of mortality level and trends. Little is known about the determinants of observed trends and, therefore, more studies are needed.

10.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-30301678

RESUMO

OBJECTIVES: To analyse changes in suicide mortality trends in Spain between 1980-2016 using joinpoint regression models. METHODS: Mortality data were obtained from the INE. For each gender, age-group-specific and standardised (overall and truncated) rates (ASR) were calculated by the direct method (using the European standard population). The joinpoint analysis was used to identify the best-fitting points where a statistically significant change in the trend occurred. RESULTS: Age adjusted mortality rates due to suicide in men was 9.8/100,000 males in 1980 and 11.8 in 2016, with an average annual increase of .8%. In women, the rates increased by 1.0% per year from 2.7 women per 100,000 in 1980 to 3.7 in 2016. The joinpoint analysis identified three turning points in the rates for both men (1986, 2000 and 2010) and women (1986, 2004 and 2010), which identify changes in the trend. In the period 2010-2016 the rates increase in women while in men the rates remain stable. CONCLUSIONS: Our work shows a marked increase in mortality by suicide in Spanish women (2010-2016) while in men the rates remain stable. Little is known about the determinants of the increase and, therefore, more studies are needed.

11.
Psiquiatr. biol. (Internet) ; 26(3): 113-115, sept.-dic. 2019. tab
Artigo em Espanhol | IBECS | ID: ibc-191662

RESUMO

INTRODUCCIÓN: El síndrome serotoninérgico es un cuadro clínico debido a altos niveles de serotonina. Está causado por el uso de uno o varios fármacos con actividad serotoninérgica de forma concomitante. Su diagnóstico es clínico y se lleva a cabo según criterios diagnósticos. CASO CLÍNICO: Paciente de 65años en seguimiento de larga evolución por trastorno afectivo bipolar con reciente instauración de tratamiento con amitriptilina. En urgencias se observa temblor distal, ataxia, bradipsiquia, desorientación temporoespacial, discinesia orolingual, miocolonías oculares y diaforesis. Se descartan posibles etiologías causantes del cuadro. RESULTADOS: Apareció un síndrome serotoninérgico tras la instauración de amitriptilina. No fueron necesarias medidas invasivas de soporte. Se retiró el tratamiento con psicofármacos y se instauraron progresivamente aquellos sin actividad serotoninérgica. CONCLUSIONES: No es necesario el uso concomitante de varios fármacos serotoninérgicos, sino que puede aparecer este síndrome con el uso de un fármaco instaurado de forma brusca


INTRODUCTION: Serotoninergic syndrome is a clinical disorder due to high levels of serotonin. It is caused by the concomitant use of one or several drugs with high serotoninergic activity. Its diagnosis is clinical, and is made following some diagnostic criteria. CLINICAL CASE: The case concerns a 65 year-old patient on long-term follow due to a bipolar affective disorder, and who recently started treatment with amitriptyline. In the Emergency Department, distal tremor was observed, as well as ataxia, bradypsychia, time-space orientation, orolingual dyskinesia, ocular myoclonus, and diaphoresis. Possible aetiological causes of the syndrome were ruled. RESULTS: A serotoninergic syndrome appeared after starting amitriptyline treatment. Invasive support measures were not necessary. The treatment with psychiatric drugs was withdrawn and gradually started with those without serotoninergic activity. CONCLUSIONS: The concomitant use of several serotoninergic drugs is not necessary, although this syndrome can appear with the use of a suddenly introduced drug


Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Idoso , Síndrome da Serotonina/induzido quimicamente , Transtorno Bipolar/tratamento farmacológico , Amitriptilina/efeitos adversos , Síndrome da Serotonina/diagnóstico , Serotoninérgicos/administração & dosagem , Índice de Gravidade de Doença , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...